ANI Pharmaceuticals, Inc. (ANIP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.58B |
| Enterprise Value | 1.62B |
| P/E Ratio | 14.53 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 1.63 |
| Price/Book Ratio | 2.49 |
| Enterprise/Revenue | 1.6 |
| Enterprise/EBITDA | 6.12 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.15 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.19 |
Income Statement
| Revenue | 883.37M |
| Revenue/Share | 46.24 |
| Gross Profit | 450.64M |
| EBITDA | 207.27M |
| Net Income | 78.34M |
| Diluted EPS | 3.32 |
Balance Sheet
| Total Cash | 375.87M |
| Total Cash/Share | 17.76 |
| Total Debt | 330.34M |
| Total Debt/Equity | 0.55 |
| Current Ratio | 2.91 |
| Book Value Per Share | 28.23 |
Price History
| 52-Week Change | -28.16 |
| 52-Week High | 99.39 |
| 52-Week Low | 69.58 |
| Moving Average 50 Days | 77.56 |
| Moving Average 200 Days | 79.14 |
Statistics
| Average Volume | 347,109 |
| Shares Outstanding | 22.73M |
| % Held by Institutions | 109.74 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
| Last Split Date | July 18, 2013 |
AD
